CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Total Comprehensive Loss, net	(Accumulated Deficit) Retained Earnings	Noncontrolling Interest in Subsidiary
Beginning Balance (in shares) at Dec. 31, 2013		31,085,000
Beginning Balance at Dec. 31, 2013	$ 160,667	$ 3	$ 246,325	$ (970)	$ (84,691)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		66,000
Vesting of restricted stock and performance stock awards (in shares)		141,000
Vesting of restricted stock and performance stock awards	(245)		(245)
Equity compensation	1,387		1,387
Foreign currency translation adjustment, net of deferred taxes	(148)			(148)
Acquisition of InteliStaf of Oklahoma, LLC	324					324
Distribution to noncontrolling shareholder	(119)					(119)
Net (loss) income	(31,534)				(31,783)	249
Ending Balance (in shares) at Dec. 31, 2014		31,292,000
Ending Balance at Dec. 31, 2014	130,332	$ 3	247,467	(1,118)	(116,474)	454
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		119,000
Vesting of restricted stock and performance stock awards (in shares)		191,000
Vesting of restricted stock and performance stock awards	(543)		(543)
Equity compensation	2,460		2,460
Foreign currency translation adjustment, net of deferred taxes	(89)			(89)
Acquisition of Mediscan (in shares)		350,000
Acquisition of Mediscan	4,724		4,724
Distribution to noncontrolling shareholder	(494)					(494)
Net (loss) income	4,954				4,418	536
Ending Balance (in shares) at Dec. 31, 2015		31,952,000
Ending Balance at Dec. 31, 2015	$ 141,344	$ 3	254,108	(1,207)	(112,056)	496
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	195,312	103,000
Vesting of restricted stock and performance stock awards (in shares)		284,000
Vesting of restricted stock and performance stock awards	$ (917)		(917)
Equity compensation	3,379		3,379
Foreign currency translation adjustment, net of deferred taxes	(34)			(34)
Distribution to noncontrolling shareholder	(701)					(701)
Net (loss) income	8,731				7,967	764
Ending Balance (in shares) at Dec. 31, 2016		32,339,000
Ending Balance at Dec. 31, 2016	$ 151,802	$ 3	$ 256,570	$ (1,241)	$ (104,089)	$ 559